Wednesday, 6 March 2019

The FDA has approved Spravato nasal spray to treat major depressive disorder

Spravato nasal spray, also known as esketamine, can now be used to treat depression in adults with treatment-resistant depression.

     
 
 


from USATODAY - Money Top Stories https://ift.tt/2TrUKZS
via IFTTT

No comments:

Post a Comment

Tough trek for Central American migrant caravan heading through Mexico to U.S. border

Many had already learned they would not be received in towns with the same hospitality that greeted previous caravans.                 ...